New Delhi: MSD has received the Drug Controller General of India’s (DCGI) approval for Keytruda (pembrolizumab) in the treatment of triple-negative breast cancer and renal cell carcinoma in adults.
Union Minister Prataprao Jadhav announces that AB PM-JAY has facilitated cashless treatment worth over Rs 1.91 lakh crore ...
Union Health Minister JP Nadda reviews the Advanced Mother and Child Centre and Advanced Neurosciences Centre at PGIMER, ...
A three-member team has been formed in Jharkhand's East Singhbhum district to investigate the recent spike in cerebral ...
The UN migration agency alerts that moving bodies of Ebola victims across Congo risks exacerbating the epidemic, with ...
Micro- and nano-plastics were detected in 84% of heart attack survivors, 40% of patients with chronic ischemic heart ...
A recent study highlights how climate change can reverse decades of progress in reducing waterborne diseases, emphasizing the ...
A staggering 80-90% of sleep apnoea cases in the Mumbai Metropolitan Region go undiagnosed due to low awareness, affecting ...
Recent Covid-19 cases in Andhra Pradesh raise concerns, but doctors clarify that these are sporadic occurrences as immunity ...
Abbott raises its 2026 profit forecast following strong performance in its diagnostics and medical devices segments, driven ...
Medtronic partners with Apollo Hospitals to launch an advanced ICU of the Future in Hyderabad, enhancing critical care ...
Michigan health officials report a significant increase in cyclosporiasis cases, now over 4,000, amid ongoing investigations ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results